Cart
sales@molnova.com
αvβ1 integrin-IN-1
CAS No. 1689540-62-2
αvβ1 integrin-IN-1( —— )
Catalog No. M33190 CAS No. 1689540-62-2
αvβ1 integrin-IN-1 is a potent and selective inhibitor of αvβ1 integrin (IC50 of 0.63 nM) with antifibrotic effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 196 | Get Quote |
|
| 5MG | 299 | Get Quote |
|
| 10MG | 470 | Get Quote |
|
| 25MG | 728 | Get Quote |
|
| 50MG | 1030 | Get Quote |
|
| 100MG | 1341 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Nameαvβ1 integrin-IN-1
-
NoteResearch use only, not for human use.
-
Brief Descriptionαvβ1 integrin-IN-1 is a potent and selective inhibitor of αvβ1 integrin (IC50 of 0.63 nM) with antifibrotic effects.
-
Descriptionαvβ1 integrin-IN-1 (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC50 of 0.63 nM. Antifibrotic effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1689540-62-2
-
Formula Weight558.65
-
Molecular FormulaC26H34N6O6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(=O)(=O)(N1[C@H](C(N[C@@H](CC2=CC=C(NC(CCCCNC(=N)N)=O)C=C2)C(O)=O)=O)CCC1)C3=CC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
GLPG-0187
GLPG-0187 (GLPG0187) is a highly potent, broad spectrum integrin receptor antagonist.
-
Bersanlimab
Bersanlimab (BI-505) is a fully human monoclonal antibody targeting Intercellular Adhesion Molecule-1 (ICAM-1), demonstrating anticancer properties and applicable for studying relapsed/refractory multiple myeloma.
-
Fibronectin CS1 Pept...
he connecting segment 1 (CS-1) is a cell attachment domain located in the type III homology connecting segment (IIICS) of fibronectin. CS1 peptide of fibronectin, which lacks the Arg-Gly-Asp-containing domain, actively inhibits tumor metastases in spontaneous and experimental metastasis models. The use of Fibronectin CS1 Peptide might offer a promising therapeutic approach for combating and preventing cancer metastasis.
